A Hemoglobin-Based Nanoparticle Delivery System Enhances the Pharmacokinetics and Efficacy of Tigecycline in Klebsiella pneumoniae Infections
BME Frontiers · 01.01.2026 · 7
DOI: 10.34133/bmef.0241 ↗Kurz gefasst
Fachartikel in der Zeitschrift BME Frontiers, online erschienen am 30.03.2026. Verfasst von Xingfang Qiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Science and Technology Innovation Key R&D Program of Chongqing, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Objective
This study aims to engineer a tigecycline–hemoglobin nanoparticle (TIG–HBNP) system to enhance the targeting effect of tigecycline (TIG) on Klebsiella pneumoniae , thereby improving its antibacterial efficacy. Impact Statement: This study represents the first report of loading TIG onto hemoglobin (HB) nanoparticles. This system utilizes the iron dependence of K. pneumoniae to enhance the targeting ability of TIG and increase the drug concentration at the infection site, thereby enhancing the antibacterial activity and providing a promising strategy for combating drug-resistant gram-negative bacterial pneumonia.
Introduction
K. pneumoniae is a gram-negative bacillus that causes severe primary pneumonia with high pathogenicity and increasing drug resistance. TIG is a key therapeutic option, but its clinical effectiveness is limited by extensive systemic distribution and insufficient drug concentration at infectious foci. HB serves as a promising protein nanocarrier and provides iron, an essential nutrient for K. pneumoniae growth, suggesting great potential for targeted antibiotic delivery.
Methods
Molecular docking was performed to analyze the binding affinity and interaction between HB and TIG. TIG–HBNP was fabricated via a drug–protein self-assembly approach. The nanoparticles were characterized in terms of particle size, zeta potential, drug-loading efficiency, morphology using transmission electron microscopy and atomic force microscopy, stability, and biocompatibility. Targeting capability was evaluated. Pharmacokinetic profiles and antibacterial activity were further assessed.
Results
Molecular docking verified stable binding between TIG and HB. TIG–HBNP exhibited a uniform spherical morphology, a particle size of approximately 200 nm, a negative surface charge, and a drug-loading efficiency exceeding 20%. The nanoparticles showed favorable stability and safety. Enhanced targeting to K. pneumoniae was confirmed in both in vitro and in vivo models. Improved pharmacokinetic behavior and enhanced antibacterial activity against K. pneumoniae were also observed.
Conclusion
TIG–HBNP enhances TIG’s therapeutic efficacy against K. pneumoniae infections. Furthermore, HB holds promise as a versatile carrier for diverse antibiotics, offering a scalable platform to combat multidrug-resistant pathogens.
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
- Chongqing Academy of Chinese Materia Medica, Chongqing 400065, China.
ORCID-Profile: Lei Luo
Förderung
- the Science and Technology Innovation Key R&D Program of Chongqing
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Special Fund for Youth Team of Southwest University
- Chongqing Science and Technology Commission
Zitieren
APA
Qiao, X., Hao, Y., Yu, Y., Qiang, Z., Wen, X., Guo, Y., Wu, Z., Shao, H., & Luo, L. (2026). A Hemoglobin-Based Nanoparticle Delivery System Enhances the Pharmacokinetics and Efficacy of Tigecycline in Klebsiella pneumoniae Infections. BME Frontiers, 7. https://doi.org/10.34133/bmef.0241
Vancouver
Qiao X, Hao Y, Yu Y, Qiang Z, Wen X, Guo Y, et al. A Hemoglobin-Based Nanoparticle Delivery System Enhances the Pharmacokinetics and Efficacy of Tigecycline in Klebsiella pneumoniae Infections. BME Frontiers. 2026;7. doi:10.34133/bmef.0241
BibTeX
@article{Qiao2026,
author = {Qiao, Xingfang and Hao, Yiwen and Yu, Yinglan and Qiang, Zhe and Wen, Xingjian and Guo, Yanlei and Wu, Zhen and Shao, Hao and Luo, Lei},
title = {A Hemoglobin-Based Nanoparticle Delivery System Enhances the Pharmacokinetics and Efficacy of Tigecycline in Klebsiella pneumoniae Infections},
journal = {BME Frontiers},
year = {2026},
volume = {7},
doi = {10.34133/bmef.0241}
}
EUVIMED